Adalimumab-Bwwd 83457-0187
Product NDC
83457-0187- Manufacturer
- Cordavis Limited
- Dosage Form
- Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 12, 2025
- Listing Expires
- December 31, 2026
- Application
- BLA761059
Need to source Adalimumab-Bwwd? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adalimumab | 40 mg/.4mL |
Drug Class
Tumor Necrosis Factor Blocker [EPC]AntibodiesMonoclonal [CS]
Packaging Options(1)
2 SYRINGE in 1 CARTON (83457-187-01) / .4 mL in 1 SYRINGE (83457-187-99)